Cited 1 times in
Blood Pressure Control in Patients with Diabetic Kidney Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 유태현 | - |
dc.date.accessioned | 2023-04-07T01:27:50Z | - |
dc.date.available | 2023-04-07T01:27:50Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1738-5997 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193934 | - |
dc.description.abstract | Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease. Blood pressure (BP) control can reduce the risks of cardiovascular (CV) morbidity, mortality, and kidney disease progression. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines have suggested the implementation of a more intensive BP control with a target systolic BP (SBP) of <120 mmHg based on the evidence that the CV benefits obtained is outweighed by the kidney injury risk associated with a lower BP target. However, an extremely low BP level may paradoxically aggravate renal function and CV outcomes. Herein, we aimed to review the existing literature regarding optimal BP control using medications for DKD. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | Korean Society of Electrolyte & Blood Pressure | - |
dc.relation.isPartOf | Electrolytes & Blood Pressure | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Blood Pressure Control in Patients with Diabetic Kidney Disease | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Yaeni Kim | - |
dc.contributor.googleauthor | Won Kim | - |
dc.contributor.googleauthor | Jwa-Kyung Kim | - |
dc.contributor.googleauthor | Ju Young Moon | - |
dc.contributor.googleauthor | Samel Park | - |
dc.contributor.googleauthor | Cheol Whee Park | - |
dc.contributor.googleauthor | Hoon Suk Park | - |
dc.contributor.googleauthor | Sang Heon Song | - |
dc.contributor.googleauthor | Tae-Hyun Yoo | - |
dc.contributor.googleauthor | So-Young Lee | - |
dc.contributor.googleauthor | Eun Young Lee | - |
dc.contributor.googleauthor | Jeonghwan Lee | - |
dc.contributor.googleauthor | Kyubok Jin | - |
dc.contributor.googleauthor | Dae Ryong Cha | - |
dc.contributor.googleauthor | Jin Joo Cha | - |
dc.contributor.googleauthor | Sang Youb Han | - |
dc.identifier.doi | 10.5049/EBP.2022.20.2.39 | - |
dc.contributor.localId | A02526 | - |
dc.relation.journalcode | J00760 | - |
dc.identifier.eissn | 2092-9935 | - |
dc.identifier.pmid | 36688208 | - |
dc.subject.keyword | Blood pressure | - |
dc.subject.keyword | Diabetes | - |
dc.subject.keyword | Kidney | - |
dc.subject.keyword | Mortality | - |
dc.contributor.alternativeName | Yoo, Tae Hyun | - |
dc.contributor.affiliatedAuthor | 유태현 | - |
dc.citation.volume | 20 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 39 | - |
dc.citation.endPage | 48 | - |
dc.identifier.bibliographicCitation | Electrolytes & Blood Pressure, Vol.20(2) : 39-48, 2022-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.